@article{377c4fc0cb1d4f738cf3311357dcf24a,
title = "Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVR ∗",
keywords = "aortic stenosis, late major/life-threatening bleeding, paravalvular aortic regurgitation, transcatheter aortic valve replacement, von Willebrand syndrome",
author = "Roxana Mehran and Sabato Sorrentino and Claessen, {Bimmer E.}",
note = "Funding Information: Dr. Mehran or her spouse has received institutional research grant support from Bayer, Beth Israel Deaconess, The Medicines Company, Bristol-Myers Squibb, Sanofi, CSL Behring, Eli Lilly, Medtronic, Novartis Pharmaceuticals, OrbusNeich, and AstraZeneca; has received consulting fees from Abbott Laboratories, Abiomed, AstraZeneca, Bayer, Boston Scientific, CardioKinetix, Cardiovascular Systems, Medscape, Siemens Medical Solution, Spectranetics, The Medicines Company, Roivant Sciences, Volcano Corporation, CSL Behring, Janssen Pharmaceuticals, Merck & Co., and Osprey Medical; has served on a data safety monitoring board for Watermark Research Partners; holds equity in Claret Medical and Elixir Medical; and serves on advisory boards of Abbott Laboratories, Bristol-Myers Squibb, Boston Scientific Corporation, Covidien, Janssen Pharmaceuticals, The Medicines Company, and Sanofi. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2018",
month = oct,
day = "30",
doi = "10.1016/j.jacc.2018.09.005",
language = "English",
volume = "72",
pages = "2149--2151",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "18",
}